General Information and Variability Data of DT
DT ID DTD0007
Gene Name SLC47A1
Protein Name Multidrug and toxin extrusion protein 1
Synonyms MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1
Gene ID
55244
UniProt ID
Q96FL8
TCDB ID
2.A.66.1.14
DT Family Multidrug/Oligosaccharidyl-Lipid/Polysaccharide (MOP) Flippase Superfamily
Multi Antimicrobial Extrusion (MATE) Family
Tissue Specificity Highly expressed in the liver , the kidney, and skeletal muscle, lower expression in the adrenal gland, testes, and heart
Function This transporter is responsible for secretion of cationic drugs across the brush border membranes. This transporter is for tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), cimetidine, N-methylnicotinamide (NMN), metformin, creatinine, guanidine, procainamide, topotecan, estrone sulfate, acyclovir, ganciclovir and also the zwitterionic cephalosporin, cephalexin and cephradin. Seems to also play a role in the uptake of oxaliplatin. Able to transport paraquat (PQ or N,N-dimethyl-4-4'-bipiridinium); a widely used herbicid.
Disease(s) Cytomegalovirus infections [ICD-11: 1D82]
Malaria [ICD-11: 1F40]
Ovarian cancer [ICD-11: 2C73]
Type 2 diabetes [ICD-11: 5A11]
Ventricular arrhythmias [ICD-11: BC71]
Herpes simplex virus infection [ICD-11: 1F00]
Maintenance of normal sinus rhythm [ICD-11: BC81.3]
Gram-positive bacteria infections [ICD-11: 1A00-1H0Z]
Genetic Polymorphisms & Epigenetic Regulations of DT
Species-, Tissue- and Disease-specific Protein Abundances of DT
Exogenous Factor Altering DT Activity
Approved Drug(s) Transported by This DT Abemaciclib Drug Info Breast cancer [ICD-11: 2C60-2C6Z] Approved [1]
Acyclovir Drug Info Shingles [ICD-11: 1.00E+91] Approved [2]
Auranofin Drug Info Rheumatoid arthritis [ICD-11: FA20] Approved [3]
Cephalexin Drug Info Gram-positive bacteria infections [ICD-11: 1A00-1H0Z] Approved [4]
Chloroquine Drug Info Malaria [ICD-11: 1F40] Approved [5]
Cimetidine Drug Info Acid reflux disorder [ICD-11: DA22] Approved [2]
Dofetilide Drug Info Maintenance of normal sinus rhythm [ICD-11: BC81.3] Approved [6]
Emtricitabine Drug Info Hepatitis B virus infection [ICD-11: 1E51.0, 1E50.1] Approved [7]
Enoxacin Drug Info Gonorrhea [ICD-11: 1A70-1A7Z] Approved [8]
Estrone sulfate Drug Info Menopausal symptoms [ICD-11: MF32] Approved [2]
Ganciclovir Drug Info Cytomegalovirus infections [ICD-11: 1D82] Approved [2]
Metformin Drug Info Type 2 diabetes [ICD-11: 5A11] Approved [9]
Procainamide Drug Info Ventricular arrhythmias [ICD-11: BC71] Approved [2]
Pyrimethamine Drug Info Isosporiasis [ICD-11: 1A33.Z] Approved [10]
Topotecan Drug Info Ovarian cancer [ICD-11: 2C73] Approved [2]
Clinical Trial Drug(s) Transported by This DT Tetraethylammonium Drug Info Hyperlipidaemia [ICD-11: 5C8Z] Phase 2 [11]
Withdrawn, Discontinued or Preclinical Drug(s) Transported by This DT Mephenoxalone Drug Info Anxiety [ICD-11: MB24.3] Preclinical [12]
N-methylpyridinium Drug Info Colon cancer [ICD-11: 2B90.Z] Preclinical [2]
Endogenous Substrate(s) N,N-dimethyl-4-4'-bipiridinium; N-methylnicotinamide; Cephalosporins; Creatinine; Guanidine
Endogenous Metabolites (EMs) Handled by This DT Creatinine EM Info Identified using MATE1-overexpressing HEK293 cells [13]
Drug-DT Affinity Assessed by Cell Line
Drug(s) with Drug-DT Affinity Data Acyclovir Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 2640 microM [2]
Cimetidine Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 170 microM [2]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 470 microM [2]
Ganciclovir Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 5120 microM [2]
Metformin Drug Info Human cervical cancer cell line (Hela)-MATE1 Km = 202 microM [9]
Metformin Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 227 microM [14]
Metformin Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 780 microM [2]
N-methylpyridinium Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 16 microM [11]
N-methylpyridinium Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 100 microM [2]
Paraquat Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 169 microM [14]
Procainamide Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 1230 microM [2]
Tetraethylammonium Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 220 microM [11]
Tetraethylammonium Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 380 microM [15]
Topotecan Drug Info Human embryonic kidney cells (HEK293)-MATE1 Km = 70 microM [2]
References
1 Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate. Clin Pharmacol Ther. 2019 May;105(5):1187-1195.
2 Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71.
3 Selection and characterization of a human ovarian cancer cell line resistant to auranofin. Oncotarget. 2017 Oct 9;8(56):96062-96078.
4 Reduced renal clearance of a zwitterionic substrate cephalexin in MATE1-deficient mice. J Pharmacol Exp Ther. 2010 Aug;334(2):651-6.
5 Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine. Antimicrob Agents Chemother. 2011 Jul;55(7):3091-8.
6 FDA Drug Development and Drug Interactions
7 Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters. Xenobiotica. 2017 Jan;47(1):77-85.
8 Functional characterization of multidrug and toxin extrusion protein 1 as a facilitative transporter for fluoroquinolones. J Pharmacol Exp Ther. 2009 Feb;328(2):628-34.
9 Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms. Am J Physiol Renal Physiol. 2010 Apr;298(4):F997-F1005.
10 Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity. Drug Metab Dispos. 2018 May;46(5):592-599.
11 A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17923-8.
12 Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1). J Pharmacol Exp Ther. 2010 Sep 1;334(3):936-44.
13 Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1. Sci Rep. 2018 Jun 18;8(1):9237.
14 Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. Pharmacogenomics J. 2009 Apr;9(2):127-36.
15 The role of microRNA in the delayed negative feedback regulation of gene expression. Biochem Biophys Res Commun. 2007 Jul 6;358(3):722-6.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.